DECAPEPTYL CR INJ
Brand:
DECAPEPTYL CR INJ
Manufacturer:
FERRING
Manufacturer Details
FERRING
Compositions:
Triptorelin acetate 3.75mg plus diluent inj inprefilled syringe,
|
Strength
|
Rate
|
Packing Style
|
|
3.75mg
|
7117.50
|
vial in prefilled syringe
|
List of Related Indications:
- Endometriosis
- Prostatic cancer-advanced cond
- Uterine fibroids prior to surg
List Of Drugs:
- Triptorelin acetate- Gonadotropin-Releasing Hormone Analog- Hormones- (July 1993)
Indication Type Description:
Drug Interaction:
Oestrogens
Indication:
Endometriosis Uterine fibroidsprior to surgery or when surgery is not possible
New Drugs Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Triptorelin Anti-cancer July 1993
Adverse Reaction:
Hot flushes, menorrhalgia Spotting, sweating,vaginal dryness Dyspareunia, decreased libido, mood changes Sleep disturbances, nausea, rash, Weight gain, transcient sight disturbances, Myalgia, asthenia, odema Arthalgia, reversible bone loss, Injection site reactions, phlebitis, Transcient hypertension, Pituitary apoplexy, hyperglycemia, Increased risk of diabetes, Increased risk of myocardial infarction, Sudden cardiac death and stroke, Rarely, vertigo, G I disturbances, Gynaecomastia, hair loss, headche, Fever, dysuria,
Contra-Indications:
Pregnancy, Non-hormonal methods of contraception must be used. Lactation Special precautions- Metabolic bone disease
Dosages/ Overdosage Etc:
Anti-cancer
Endometriosis Uterine fibroids prior to surgery or when surgery is not possible
Start during first 5 days of menstrual cycle Endometriosis-
Dosage-
One vial by i.m. injection every 28 days for maximum 6 months Fibroids- One vial by i.m. injection every 28 days for minum 3 months
Consider uterine lelomyosarcoma if no change or an increase in uterine volume Children - not applicable
Pregnancy and lactation:
Contraindicated for use during pregnancy and lactation Observe caution
